Neurodivergence can be a superpower if supported appropriately. In fact, 40-50% of founders are neurodivergent, indicating its potential for creativity and innovation. However, many are held back by the challenges that come with it.

Steph Hamill is solving this problem as the Co-Founder of Divergence Supplements. Their lead product, Gamma Focus, is the first natural superblend specifically formulated to support the needs of divergent minds.

Steph began her career in marketing, business development, and innovation. She now exclusively applies this expertise to making a social impact, such as in her role as senior entrepreneur-in-residence and MBA faculty for Oneday, an EdTech accelerator that supports entrepreneurs in launching and scaling their businesses. She has personally mentored over 250 founders.

Steph was also the first investor for Mettle - the first mental fitness toolkit for men - which featured on MindTech as our very first episode.

In this episode, we discuss:

• Steph’s personal experience of being treated for neurodivergence, which gave her the insight to create a thriving business in this space

• Redefining neurodivergence and unleashing its advantages

• Facilitating community with conversational AI

Steph is currently writing a book on neurodivergent entrepreneurs. So, if you are a neurodivergent entrepreneur, you can reach out to Steph on LinkedIn.

Access the MindTech Matrix - the first map of mental health technology startups organised by the problem they’re solving and the solution they’re building.

Discover insights & tools for your mind at ⁠The Mind, Explored.⁠

In children, existing treatments for depression are effective in only 60% of cases. After treatment, 50 - 75% experience a relapse. Why are these outcomes so poor? And how can we make progress?

In this episode, we answer these questions and discuss:

1. 3 overlooked factors contributing to young people’s mental health
2. How parents can better support their children through mental health challenges
3. How to measure DSM-5 outcomes in fewer questions for young people

Peter Templeton founded The William Templeton Foundation for Young People’s Mental Health (YPMH) - a charitable foundation working to improve the lives of young people by facilitating innovation to resolve mental health conditions.

On June 19th 2024, YPMH are co-hosting ‘Collaborate to innovate: Working together to transform mental health outcomes’ at the University of Cambridge. Each session is relevant to MindTech, but the one I am most looking forward to is the middle session on evaluating and prioritising innovations. Learn more and buy tickets here.

Access the MindTech Matrix - the first map of mental health technology startups organised by the problem they’re solving and the solution they’re building.

Discover insights & tools for your mind at ⁠The Mind, Explored.⁠

Clare Kennedy Purvis is a Stanford-trained clinical psychologist who has applied her understanding of the mind to building digital mental health interventions all throughout her career, including as the:

• VP of Clinical Product & Content Development at Headspace
• Clinical Product Lead in the Mental Health Centre of Excellence at Google
• Head of Clinic Product at Lantern
• Chief Product Officer at Mindcure

Clare is also the Founder of WELL - a business leadership community for women clinicians and scientists in digital health.

In this episode, we discuss:

• How Headspace relieves acute distress (painkiller effect) and then guides users towards a long-term preventative approach (vitamin effect)
• Aligning value-based outcomes with payment models
• Clare’s bold bet on the next opportunity for innovation in MindTech

See where Headspace fits into the MindTech Matrix - the first map of mental health technology startups organised by the problem they’re solving and the solution they’re building.

Discover insights & tools for your mind at ⁠The Mind, Explored.⁠